OSTEOGENESIS IMPERFECTA (OI)
Clinical trials for OSTEOGENESIS IMPERFECTA (OI) explained in plain language.
Never miss a new study
Get alerted when new OSTEOGENESIS IMPERFECTA (OI) trials appear
Sign up with your email to follow new studies for OSTEOGENESIS IMPERFECTA (OI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to strengthen fragile bones
Disease control Recruiting nowThis study is testing an investigational drug called AGA2115 for adults with osteogenesis imperfecta (OI), also known as brittle bone disease. The main goal is to see if the drug can safely increase bone mineral density and reduce the number of fractures. For the first year, part…
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Phase: PHASE2 • Sponsor: Angitia Incorporated Limited • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Scientists probe hidden heart risks in brittle bone disease
Knowledge-focused Recruiting nowThis study aims to understand how brittle bone disease (Osteogenesis Imperfecta) affects the heart over time. Researchers will observe 40 children and adults with the condition for five years, using standard heart tests and questionnaires. The goal is to gather evidence to help d…
Matched conditions: OSTEOGENESIS IMPERFECTA (OI)
Sponsor: Istituto Ortopedico Rizzoli • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC